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1. Introduction
As biological receptors, biosensors offer enormous potential for detecting a wide range of
analytes in the food industry and in drug residue monitoring. For immunobiosensors, a
probe is required to conjugate with a protein to monitor a specific interaction, and these
probes possess reactive functionalities convenient for covalent linkage to antibodies and oth‐
er protein molecules. As the usage of these probes becomes standardized, an increasing
number of instruments have become widely available for measuring their signals. The de‐
velopment of multiplexing-capable immunobiosensors offers the possibility to simultane‐
ously measure many different analytes in a small sample volume. The advantages of a
multiplexing-capable immunobiosensor increase with each additional analyte analyzed and
can be translated into substantial savings in the cost of reagents and time.
In this chapter, we review the main applications of multiplexing-capable immunobiosensors
and illustrate their multiplexing capabilities by example of a suspension array system. First,
the principle of a suspension array system is introduced. Microspheres are the common car‐
rier in suspension array systems. Microspheres with different sizes or colors or a single mi‐
crosphere with different fluorescent probes are used for multiplexed immunoassays (IAs).
Second, we list the main applications of suspension array systems. Suspension array tech‐
nology was initially widely used in nucleic acid detection and genotyping. Recently, it has
been gradually introduced for the detection and quantification of many viruses and antibod‐
ies in various samples based on IAs. However, there are also quite a few reports on multi‐
plexed detection of low molecular weight compounds, such as drug residues, because this is
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more difficult for competitive IAs than for noncompetitive (sandwich) ones to meet the sen‐
sitivity and specificity requirements.
In the following section, a rapid, sensitive, multiplex, and competitive IA model based on a
suspension array system is described. Antigens are covalently bound to different coded
functional carriers to compete for antibodies with analytes in sample, and the fluorescent
probe is used as a transducer. As the fluorescence signals are measured, the analytes can be
screened simultaneously.
2. Multiplexing-capable suspension array system
2.1. History of high-throughput technology
High-throughput screening (HTS) has been developed as an advanced technique to perform
large-scale screening of samples to analyze biological or chemical activity (Burbaum & Sigal,
1997; Hill, 1998). Descriptions of this technology first appeared in the scientific literature as
early as the 1980s. Over the past 30 years, the developments in the scale, efficiency, and tech‐
nical level of HTS have rendered it a key technology in the areas of international drug re‐
search, genomics, proteomics, and analytical techniques (Burbaum, 1998; Eggeling et al.,
2003; Haber et al., 2005).
HTS technology can be used to construct a micro-biochemical analysis system by integrating
micromachining technology with microelectronics technology. With a large number of nu‐
cleic acid fragments with specific sequence or proteins fixed on a functional carrier, as well
as labeled reactants (nucleic acids or protein) reacting in the reaction system, HTS can quan‐
titatively determine the target analytes in samples by detecting the intensity of fluorescent
reporter signals and can screen for compounds, nucleic acids, proteins, cells, and other bio‐
logical components. Multiplexing and miniaturization are current trends in the develop‐
ment of HTS technology. Assays performed on large numbers of candidates in small sample
volumes and using target analytes (e.g., antigens, antibodies, nucleotides, and peptides) can
be screened. HTS has important application prospects in the fields of drug discovery, drug
screening, and diagnostics, and suspension array technology is one of the representatives in
a variety of new high-throughput analysis methods.
2.2. Suspension array system and its detection principles
The suspension array system is based on encoded microspheres, which are both the encoded
carrier and analysis platform for the probes. Compared with traditional flat biochips, the ad‐
vantages of suspension biochips are as follows (Meza, 2000; Battersby, 2000; Grondahl,
2000):
• Liquid phase conditions are conducive for maintaining the natural conformation of pro‐
tein molecules, and the use of microspheres as the solid carrier in the assay leads to reac‐
tion kinetics approaching phase conditions;
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• Differently coded microspheres conjugated to the capture antibody or target molecules
are required for each reaction and can be flexibly pooled together for a multiplexed assay
and separated later during data acquisition, reducing the analysis cost;
• These “no-wash” assays eliminate the need for washing steps; and
• Suspension array systems offer an approach for large-scale screening, which is an impor‐
tant breakthrough in the number of analytes compared with traditional flat chips.
Of course, suspension array system has some shortcomings: optimization of multiple liquid
phase reaction conditions is more difficult, and the cross reaction and its elimination is more
complicated which would require thorough analysis. In addition, on-line monitoring of ana‐
lytes could not be done using suspension array system.
In spite of this, with widespread prospects for application,suspension array technology is
becoming a research focus.
Microsphere-based suspension array technology consists of a detection platform and micro‐
spheres. Such technology has a long history of simplifying the separation of biological sys‐
tems, the positioning of biological interactions, and signal amplification in the biomedical
field (Brown, 1987; Deleo, 1991). After decades of development, microsphere-based analysis
techniques have now been developed into a wide range of analysis systems to meet specific
needs. However, despite their various forms, the basic principle of these assays is micro‐
spheres pre-encoded by chemical, spectral, electronic, or physical methods. Each micro‐
sphere encodes specific identifying information, and these microspheres offer binding sites
for bioconjugation. Before testing, differentially coded microspheres are coupled with the
capture antibody or target molecules (e.g., antigens, oligonucleotides, receptors, or peptides)
that are required for each reaction. Then, a reporter molecule labeled with a fluorescent
marker (e.g., phycoerythrin or Alexa 532) binds to the analytes captured on the micro‐
spheres in the sample solution. The bound microspheres are passed through the detection
channel and separated during data acquisition.
It can be concluded that microspheres-based suspension array technology includes two key
factors: 1) coding and decoding a large number of microspheres, and 2) conjugating capture
antibodies or target molecules with functional microspheres for the identification of differ‐
ent analytes.
As a typical multiplexed microsphere-based suspension array platform, the Lumi‐
nex®xMAP™ system is a flow-based dual-laser system capable of analyzing and reporting
up to 100 different analytes in a single reaction vessel in just a few seconds per sample (Du‐
bar, 2006).The target molecules are fixed on the carrier via non-covalent or covalent bonds.
Usually, reactive functionalities on microspheres provide the means to specifically label cer‐
tain target groups on capture antibodies or target molecules in the form of a covalent bond.
The common covalent bonds include amide, ester, and ether bonds (Deleo, et al. 2000; Meh‐
naaz, et al. 2003).
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3. Competitive model based on IA
3.1. Immunoassay (IA)
Immunoassay technology is a type of analysis method based on antigen-antibody specifici‐
ty, identification, and binding. Depending on the available antigen or antibody reagents,
one can achieve qualitative and quantitative detection of a specific analyte.
Immunoassay is  a  very popular method,  has been rapidly developed by many research
laboratories,and many versions are commercially available due to their rapid, simple, spe‐
cific detection capabilities. Different types ofIA with specific characteristics listed in Table
1 would give a comparison. In the early 1990s, IA, together with liquid chromatography
(LC)  and gas  chromatography (GC),  were  called  three  of  the  most  advanced  analytical
techniques by the Association of small molecule residue determination mainly uses com‐
petitive IA.
type characteristics
Radioimmunoassay,RIA Reagent with low cost, high sensitivity; complex operation, radioactive
pollution, short duration
enzyme immunoassay,EIA Reagent with low cost, simple operation; low sensitivity, suitable for
qualitative and semi-quantitative determination
chemiluminescent enzyme
immunoassay,CIZIA
Simple operation, low cost, high sensitivity, stable reagent; working curve
drift with time
fluorescence immunoassay,FIA High sensitivity, stable reagent; complex operation, high cost of reagents,
the background interference
Table 1. Different types ofIA with specific characteristics
3.2. Operational process of competitive IA
The basic operational process of  the competitive model includes fixing the antigen on a
solid support,  pooling the sample (antigen) and antibody in the reaction vessel together
for competitive interaction, and adding a reporter molecule labeled with a marker to the
sample solution to bind to the analyte captured by the antigen fixed on the solid carrier.
Competitive IA can quantitatively determine the analyte in a sample indirectly by detect‐
ing the intensity of the reporter signals because the detection signal is inversely propor‐
tional to the concentration of the analyte in a competitive model. Small molecular weight
compounds, such as drug residues, and theconsist of preparation of the immunogen (arti‐
ficial antigen), production of the antibody, and optimization of reaction conditions.
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Small molecular weight compounds enzyme-linked immunosorbent assay became an inevi‐
table trend, and multiplexed assays have been further simplified by introducing immuno‐
sensors, which are available for HTS and automation. Remarkably, optical immunosensors
are widely employed to their full potential.
4. Applications of a suspension array system based on competitive IA
4.1. Main applications of a suspension array system
Microsphere-based  suspension  array  technologies,  such  as  the  Luminex®  xMAP™  sys‐
tem,  offer  a  flexible  technical  platform  based  on  Flexible  Multi-Analyte  Profiling
(xMAP) technology, which was recently developed (Morgan, et al.  2004).  Such technolo‐
gy combines encoded microspheres with flow cytometry.  Two lasers analyze the micro‐
spheres  in  a  flow stream. The first  laser  indentifies  each microsphere-associated analyte
according to the fluorescent  signature of  the microsphere,  and the second measures the
reporter  molecules  attached  to  the  analytes  quantify  the  amount  of  analyte  (Nolan
&Sklar, 2002).
Many  studies  have  been  performed  in  the  field  of  clinical  diagnosis  and  genomic  re‐
search  by  combining  flow-based technology  with  IA (Yan et  al.  2004;  Fuja  et  al.  2004).
Beads  of  different  sizes/colors  or  a  single  bead  with  different  fluorescent  probes  are
used  for  multiplexed  IA.  Previous  studies  using  multiplexed  assay  technology  include
detection  of  thyroxine  and  thyrotropin  from  blood  spot  samples  for  congenital  hypo‐
thyroidism  (Bellisario,  et  al.  2000),  antibodies  to  West  Nile  virus  in  human  serum  and
cerebrospinalfluid (Wong et al.  2004), and Ig classes in serum and stool samples (Dasso,
et  al.  2002),  as  well  as  identifying  response  patterns  in  hyperinflammatory  diseases
(Hsu,  et  al.  2008)  and  cytokines  in  human  serum  (Ray  et  al.  2005).  As  an  open  plat‐
form,  xMAP was gradually  introduced for  the detection and quantification of  many vi‐
rus  and  drug  residues  in  food  and  agriculture  samples.  For  example,  a  multiplex
microsphere  IA  was  developed  to  monitor  seed  potatoes  for  potato  viruses  X,  Y,  and
PLRV (Bergervoet et  al.  2008),  and a flow cytometric  IA was developed to detect  sulfo‐
namide residues in milk (de Keizer et al.  2008).
Notably, the multiplexed IAs using suspension array technology are currently more preva‐
lent for analyzing viruses and antibodies than detecting small molecular weight compounds
such as drug residues.
A recent study reports the use of a suspension array system for the detection of drug resi‐
dues, highlighting its simplicity, low cost, specificity, and multiplexing capabilities (Zou et
al. 2008). Fig. 1 shows the competitive IA strategy and the detection principles of the Lumi‐
nex® xMAP™ system.
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Figure 1. Microsphere-based competitive IA strategy. EX: excitation laser; RP: reporter laser; CL: clarification laser
4.2. Detection of low molecular weight compounds using an immunobiosensor based on
competitive IA
Low molecular weight compounds are widely utilized as animal drugs, food additives, and
pesticides to pursue maximum productivity and profits directly or indirectly in food prod‐
ucts. However, residues of such low molecular weight compounds in food products are det‐
rimental to human health. For instance, clenbuterol (313.65u), a β-adrenergic agonist growth
promoter, is associated with a series of severe food poisoning outbreaks around the world.
Therefore, quantitative analysis of such low molecular weight compounds is essential to
safeguardpublic health, prevent their illicit use, and facilitate governmental regulation and
surveillance.
In comparison to conventional ELISAs, a microsphere-based competitive fluorescent IA
(MCFI) has been established to analyze low molecular weight compounds in food as descri‐
bed in the literature (Zou et al. 2008). This method utilizes an artificial antigen bound to 4-
μm polystyrene beads together with an FITC-conjugated monoclonal antibody. In this
indirect IA, the fluorescent conjugated antibody is bound to an artificial antigen fixed on the
polystyrene beads and subsequently analyzed by multiparameter flow cytometry. Quantifi‐
cation is based on the intensity of the fluorescent reporter signal: the higher the hazardous
low molecular weight compound concentration, the lower the fluorescence intensity.
It is worth pointing out that the entire process is specially designed for aqueous systems that
are bio-compatible with proteins’ native structures. To illustrate the feasibility of this novel
strategy, clenbuterol was selected as a practical analyte. Compared to traditional IAs, such
as ELISA, microsphere-based competitive fluorescent IA by flow cytometry offers compara‐
ble or higher sensitivity, better reproducibility, and a greater dynamic range.
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4.3. Simultaneous detection of antibiotics in raw milk
Antibiotics, as conventional veterinary medicine, are widely used for the treatment and pre‐
vention of microbial infections. Antibiotic residues can enter the body and are metabolized
by the liver. Further, antibiotics and their metabolites can impair the nervous and psychiat‐
ric systems, circulatory system, and even brain function before elimination by the kidneys.
Thus, every country has established a maximum residue limit (MRL) for the total amount of
antibiotics in various food products (e.g., raw milk) to bolster public health and the security
of international trade in food products. For example, the European Union established a MRL
of 100 μg/L for the total amount of gentamycin in milk and, 150μg/L for the total amount of
kanamycin in milk.
As previously published (Wang, et al. 2011), we applied suspension array technology to de‐
velop an indirect multiplexed competitive IA for simultaneous detection of antibiotic resi‐
dues, such as kanamycin and gentamycin, in raw milk. First, we successfully produced a
monoclonal antibody (McAb) against gentamycin. Then, with the coating antigens of kana‐
mycin and gentamycin attached to differentially encoded beads and R-phycoerythrin-conju‐
gated goat anti-mouse IgG as the fluorescent probe, an indirect bead-based competitive
fluorescent IA using a Bio-PlexTM 200 suspension array system was developed. To develop
the actual application, raw milk samples spiked with kanamycin or gentamycin were ana‐
lyzed using ELISA and our Bio-PlexTM assay for comparison.
A McAb against gentamycin was successfully obtained, and an indirect bead-based compet‐
itive fluorescent IA was developed for rapid detection of small molecule drug residues in
animal-derived food products, such as raw milk. Notably, even with the matrix’s back‐
ground interaction with milk, the fluorescent intensities detected from raw milk samples are
still strong enough and sufficient to detect the lowest allowable quantity of the antibiotics in
milk at the MRL level. In fact, cephalosporins and sulfonamides, which are used worldwide
in cows and are also tested in milk, could be added to the assay because the suspension ar‐
ray technology permits up to 100 different assay combinations. Compared to ELISA, the
multiplexed assay had a similar limit of detection,but its ability to simultaneously measure
several analytes in a single sample is superior to ELISA. Details of limit of detection, detec‐
tion time, etc. are described in the literature (Wang, et al. 2011).
With a particular focus on applications in real samples containing complex matrices, kana‐
mycin was intraperitoneally administered to three cows at a dose of 10 mg/kg (twice per day
for 3 days), and gentamycin was administered in another three cows in the same way.
Sixty raw milk samples were collected from these six cows. Fig. 2 and Fig. 3 show the com‐
parison of the detection results obtained by the bead-based competitive fluorescent IA and
ELISA. The analysis shows that there is good correlation between the results of the multi‐
plexed assay and those of ELISA. Basically, the kanamycin concentrations in raw milk de‐
creased gradually. Seven hours after the last injection, the residues were present at 190
ng/ml, and 20 h later, the residues were reduced to 40 ng/ml, which is lower than the MRL
provided by the European Union. The gentamycin concentrations in raw milk decreased in
a similar manner.
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Figure 2. Raw milk depletion profile of kanamycin after intramuscular administration to cows.
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Figure 3. Raw milk depletion profile of gentamycin after intramuscular administrationto cows.
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4.4. Other applications using immunobiosensors based on competitive IA
To illustrate the feasibility of this competitive strategy, we present an example of the simul‐
taneous detection of antibiotic residues like kanamycin and gentamycin, though other relat‐
ed reports exist.
Sulfonamides are a class of antibiotics used in veterinary and human medicine for the treat‐
ment and prevention of microbial infections. The European Union (EU) established a MRL
of 100 μg/L for the total amount of sulfonamides in milk. To detect sulfonamides in raw
milk, a multi-sulfonamide flow cytometric IA (FCI) was developed using the xMAP tech‐
nology as described in the literature (de Keizer, et al. 2008). In this automated FCI, a previ‐
ously developed biotinylated multi-sulfonamide mutant antibody (M.3.4) was applied in
combination with fluorescent  beads,  directly  coated with a  sulfathiazole  derivative,  and
streptavidin–phycoerythrin (SAPE) for detection.  Because of  differences in sensitivity to‐
ward different sulfonamides, the FCI was considered and validated as a qualitative screen‐
ing assay.
Simultaneous detection for three kinds of veterinary drugs: chloramphenicol (CAP), clenbu‐
terol, and 17-beta-estradiol has also been reported (Liu, et al. 2009). Conjugates of chloram‐
phenicol and clenbuterol coupled with bovine serum albumin were synthesized and
purified. Probes for the suspension array were created by coupling the three conjugates on
fluorescent microspheres, and the microstructures on the microspheres’ surfaces were ob‐
served by scanning electron microscopy, which was direct confirmation for successful conju‐
gate coupling. The addition of conjugates and the amounts of antibodies were optimized
and selected, respectively. The suspension array is specific and has no significant cross-reac‐
tivity with other chemicals. Meanwhile, unknown samples were analyzed by suspension ar‐
ray and ELISA in comparison with each other. The errors found for the detection of the
unknown samples were relatively small in both methods, but the detection ranges of the
suspension array are broader and more sensitive than that of traditional ELISA.
Further research investigated the simultaneous quantitative determination of five antibiotics
(tylosin, tetracycline, gentamycin, streptomycin, and chloramphenicol) in milk in the same
research laboratory (Su, et al. 2011). A novel treatment of milk samples for the suspension
array with diethyl ether was performed, which greatly reduced the interference of the dis‐
turbing components in milk on the reaction results with no significant effect on detection
sensitivity. Compared to using a biotin-labeled monoclonal antibody, using a secondary bio‐
tinylated antibody further increased the detection sensitivity. Thus, suspension assay tech‐
nology is powerful for the rapid, quantitative analysis of multiple drug residues.
5. Conclusions
In this chapter, the competitive IA method with immunobiosensor as a detection platform
was first used with a single analyte in simple buffer for its sensitivity, specificity, and re‐
peatability, and then complex substrates such as milk were introduced. Thousands of actual
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samples were screened for confirmation of this multiplexing-capable immunobiosensor
based on competitive IA. As an easy, effective, and time-saving method, the multiplexing-
capable immunobiosensor based on competitive IA has the potential to detect small molecu‐
lar weight compounds in various actual applications. Previous research has laid a firm
foundation for simultaneous screening of multiple analytes in food products. Future re‐
search should focus on adding more analytes to the assay and establishing a reliable multi‐
plexed assay to detect analytes in additional samples, such as tissue and fat. It is a flexible
technical platform with multiplexing capabilities.
Acknowledgments
This work was partially supported by a Strategic Eleventh Five-Year Science and Technolo‐
gy Supporting Grant No: 2009BAK61B04 and Special Funded Projects of the Fundamental
Research Funds from the Chinese Academy of Inspection and Quarantine of China No:
2010JK016.
Author details
Yanfei Wang1, Mingqiang Zou1, Ping Yao2 and Yuande Xu3
1 Chinese Academy of Inspection and Quarantine, China
2 The People’s Hospital of Juxian, China
3 COFCO Corporation, China
References
[1] Burbaum, J. J., & Sigal, N. H. (1997). New technologies for high-throughput screen‐
ing.Curr.Opin. Chem. Biol. , 1, 72-78.
[2] Hill, D. C. (1998). Novel screen methodologies for identification of new microbial
metabolites with pharmacological activity. Adv. Biochem. Eng. Biotechnol. , 59,
73-121.
[3] Burbaum, J. J. (1998). Miniaturization technologies in HTS: how fast, how small, how
soon? Drug Discov. Today , 3, 313-322.
[4] Eggeling, C., Brand, L., Ullmann, D., et al., & (2003, . (2003). Highly sensitive fluores‐
cence detection technology currently available for HTS.Drug Discov.Today. , 8,
632-641.
Multiplexing-Capable Immunobiosensor Based on Competitive Immunoassay
http://dx.doi.org/10.5772/52486
197
[5] Haber, C., Boillat, M. ., & Schoot, B. V. D. (2005). Precisenanoliter fluid handling sys‐
tem with integrated high-speed flow sensor. Assay Drug Dev. Technol. , 3, 203-212.
[6] Meza, M. B. (2000). Bead-based HTS applications in drug discovery.Drug Discov.To‐
day (Suppl.). , 5, 38-41.
[7] Battersby, B. J., Bryant, D., Meutermans, W., et al. (2000). Toward larger chemical li‐
braries: encoding with fluorescent colloids in combinatorial chemistry. J. Am. Chem.
Soc. , 122, 2138-2139.
[8] Grondahl, L. B., Bronwyn, J., Bryant, D., et al. (2000). Encoding combinatorial libra‐
ries: a 104novel application of fluorescent silica colloids. Langmuir. , 16, 9709-9715.
[9] Brown, W., & (1987, . (1987). Microparticle-capture membranes: Application to Test
Pack hCG-urine. Clin. Chem. , 33, 1567-1568.
[10] Deleo, D. T., & (1991, . (1991). Particle-enhanced turbidimetric IA of sex-hormone-
binding globulin in serum.Clin. Chem. , 37, 527-531.
[11] Jane, A., Ferguson, F. J., Walt, D. R., & (2000, . (2000). High-density fiber-optic DNA
random microsphere array.Anal. Chem. , 72, 5618-5624.
[12] Mehnaaz, F. A., Romy, K., Adrian, P. G., et al. (2003). DNA hybridization and dis‐
crimination of single-nucleotide mismatches using chip-based microbead arrays.
Anal. Chem. , 75, 4732-4739.
[13] Bellisario, R., Colinas, R. J., Pass, K. A., & (2000, . (2000). Simultaneous Measurement
of Thyroxine and Thyrotropin from Newborn Dried Blood-Spot Specimens Using a
Multiplexed Fluorescent Microsphere IA.Clini. Chem. , 46, 1422-1424.
[14] Bergervoet, J. H. W., Peters, J., van Beckhoven, J. R. C. M., van den, Bovenkamp. G.
W., Jacobson, J. W., & van der Wolf, J. M. (2008). Multiplex microsphere immuno-de‐
tection of potato virus Y, X and PLRV. J. Virol. Methods. , 149, 63-68.
[15] Dasso, J., Lee, J., Bach, H., Mage, R. G., & (2002, . (2002). A comparison of ELISA and
flow microsphere-based assays for quantification of immunoglobulins. J. Immunol.
Methods. , 263, 23-33.
[16] de Keizer, W., Bienenmann-Ploum, M. E., Bergwerff, A. A., Haasnoot, ., & , W.
(2008). Flow cytometric IA for sulfonamides in raw milk. Anal.Chim.Acta. , 620,
142-149.
[17] Fuja, T., Hou, S., Bryant, P., & (2004, . (2004). A multiplex microsphere bead assay for
comparative RNA expression analysis using flow cytometry.J Biotechnol. , 108,
193-205.
[18] Hsu, H. Y., Wittemann, S., Schneider, E. M., Weiss, M., Joos, ., & , T. O. (2008). Sus‐
pension microarrays for the identification of the response patterns in hyperinflam‐
matory diseases. Med. Eng. Phys. , 30, 976-983.
[19] Liu, N., Su, P., Gao, Z. X., Zhu, M. X., Yang, Z. H., Pan, X. J., Fang, Y. J., & Chao, F. H.
(2009). Simultaneous detection for three kinds of veterinary drugs: Chloramphenicol,
State of the Art in Biosensors - Environmental and Medical Applications198
clenbuterol and 17-beta-estradiol by high-throughput suspension array technology.
Anal.Chim.Acta. , 632, 128-134.
[20] Morgan, E., Varro, R., Sepulveda, H., Ember, J. A., Apgar, J., Wilson, J., Lowe, L.,
Chen, R., Shivraj, L., Agadir, A., Campos, R., Ernst, D., & Gaur, A. (2004). Cytometric
bead array: a multiplexed assay platform with applications in various areas of biolo‐
gy. Clin.Immunol. , 110, 252-266.
[21] Nolan, J. P. ., Sklar, L. A., & (2002, . (2002). Suspension array technology_evolution of
the flat-array paradigm.TRENDS Biotechnol. , 20, 9-12.
[22] Ray, C. A., Bowsher, R. R., Smith, W. C., Devanarayan, V., Willey, M. B., Brandt, J. T.,
& Dean, R. A. (2005). Development, validati. on, and implementation of a multiplex
IA for the simultaneous determination of five cytokines in human serum. J. Pharma‐
ceut. Biomed. , 36, 1037-1044.
[23] Wong, S. J., Demarest, V. L., Boyle, R. H., Wang, T., Ledizet, M., Kar, K., Kramer, L.
D., Fikrig, E., Koski, ., & , R. A. (2004). Detection of Human Anti-Flavivirus Antibod‐
ies with a West Nile Virus Recombinant Antigen Microsphere IA. J. Clin. Microbiol. ,
42, 65-72.
[24] Yan, X. M., Tang, A. J., Schielke, E. G., Hang, W., & Nolan, J. P. (2004). On the devel‐
opment of a microsphere-based multiplexed IA for influenza virus typing and sub‐
typing by flow cytometry. International Congress Series. , 1263, 342-345.
[25] Zou, M. Q., Gao, H. X., Li, J. F., Xu, F., Wang, L., & Jiang, J. Z. (2008). Rapid determi‐
nation of hazardous compounds in food based on a competitive fluorescence micro‐
sphere IA.Anal.Biochem. , 374, 318-324.
[26] Wang, Y. F., Wang, D. N., Zou, M. Q., Jin, Y., Yun, C. L., Gao, ., & , X. W. (2011). Ap‐
plication of suspension array for simultaneous detection of antibiotic residues in raw
milk.Analytical letters. , 44, 2711-2720.
[27] Dubar, S. A. (2006). Applications of Luminex® xMAP™ technology for rapid, high-
throughput multiplexed nucleic acid detection. Clin.Chim.Acta. , 363, 71-82.
[28] Su, P., Liu, N., Zhu, M. X., Ning, B. A., Liu, M., Yang, Z. H., Pan, X. J., Gao, ., & , Z. X.
(2011). Simultaneous detection of five antibiotics in milk by high-throughput suspen‐
sion array technology. Talanta. , 85, 1160-1165.
Multiplexing-Capable Immunobiosensor Based on Competitive Immunoassay
http://dx.doi.org/10.5772/52486
199

